Active Pharmaceutical Ingredient

Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations. The preparation is a macromolecular complex, consisting of iron(III)-hydroxide (trivalent iron, Fe3+) and the carrier polymaltose and is available in solid form as a film-coated or chewable tablet and in liquid form as a syrup, drinkable solution, or drops. It is used for treating iron deficiency without anemia (latent iron deficiency) or with anemia (apparent iron deficiency). Prior to administration, the iron deficiency should be diagnostically established and verified via laboratory tests (e.g., low ferritin concentration, low transferrin saturation).

Alpha-amylase (-amylase) is an enzyme EC 3.2. 1.1 that hydrolyses alpha bonds of large, alpha-linked polysaccharides, such as starch and glycogen, yielding shorter chains thereof, dextrins, and maltose. It is the major form of amylase found in humans and other mammals.

yellow powder

Bromhexine is a mucolytic drug used in the treatment of respiratory disorders associated with viscid or excessive mucus. It was originally derived as an extract derivative called vasicinone from the Indian plant, Adhatoda vasica. It was patented in 1961 and came into medical use in 1966.

Caffeine is a metabolic and Central nervous system stimulant and occurs naturally in coffee beans, tea leaves and cocoa nuts. C

Caffeine is a metabolic and Central nervous system stimulant and occurs naturally in coffee beans, tea leaves and cocoa nuts. C

Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain

Haloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations in alcohol withdrawal. It may be used by mouth or injection into a muscle or a vein. Haloperidol typically works within 30 to 60 minutes. A long-acting formulation may be used as an injection every four weeks in people with schizophrenia or related illnesses, who either forget or refuse to take the medication by mouth.